{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:24:39Z","timestamp":1780629879245,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.cancergencyto.2007.02.007","type":"journal-article","created":{"date-parts":[[2007,6,6]],"date-time":"2007-06-06T11:20:17Z","timestamp":1181128817000},"page":"117-124","source":"Crossref","is-referenced-by-count":13,"title":["Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study"],"prefix":"10.1016","volume":"175","author":[{"given":"Linda D.","family":"Cooley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleen","family":"Chenevert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Shuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis A.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald H.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Devidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Linda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Camitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2007.02.007_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","article-title":"Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia","volume":"14","author":"Smith","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib2","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra023001","article-title":"Mechanisms of disease: acute lymphoblastic leukemia","volume":"350","author":"Pui","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib3","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1182\/blood-2004-04-1616","article-title":"Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital","volume":"104","author":"Pui","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1200\/JCO.1992.10.4.606","article-title":"Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B progenitor cell ALL of childhood: a Pediatric Oncology Group study","volume":"10","author":"Trueworthy","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00043426-199605000-00004","article-title":"Comparison of fluorescence in situ hybridization, cytogenetic analysis, and DNA index analysis to detect chromosomes 4 and 10 aneuploidy in pediatric acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"18","author":"Martin","year":"1996","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib6","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.2000.18.9.1876","article-title":"Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (>50 chromosomes)","volume":"18","author":"Heerema","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.leu.2403673","volume":"19","author":"Sutcliffe","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib8","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1002\/cncr.11841","article-title":"Reassessment of the prognostic significance of hypodiploidy in pediatric patients with acute lymphoblastic leukemia","volume":"98","author":"Raimondi","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib9","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1200\/JCO.1994.12.9.1939","article-title":"Comparison of two schedules of intermediate dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a POG study","volume":"12","author":"Land","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib10","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1200\/JCO.1998.16.8.2840","article-title":"Consolidation with anti-metabolite based therapy in standard risk acute lymphocytic leukemia: a Pediatric Oncology Group study","volume":"16","author":"Harris","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib11","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/sj.leu.2401886","article-title":"Treatment of children with early pre-B and pre-B acute lymphoblastic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group study","volume":"14","author":"Harris","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib12","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.leu.2402132","article-title":"A comparison of early intensive methotrexate\/mercaptopurine with early intensive alternating therapy for high risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Phase III randomized trial","volume":"15","author":"Lauer","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib13","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1038\/sj.leu.2401965","article-title":"Long-term results of treatment studies in childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986\u20131994","volume":"14","author":"Maloney","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib14","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.2000.18.6.1285","article-title":"Intensification with intermediate dose intravenous methotrexate is effective for children with lower risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"18","author":"Mahoney","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib15","unstructured":"Mitelman F, editor. ISCN 1991: Guidelines for cancer cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. In: Basel: S. Karger, 1991."},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib16","article-title":"ISCN 2005: an international system for human cytogenetic nomenclature (2005)","year":"2005"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Nonparametric estimator from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples","volume":"35","author":"Peto","year":"1977","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib20","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1200\/JCO.1997.15.3.1150","article-title":"TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance","volume":"15","author":"Rubnitz","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib21","first-page":"362","article-title":"AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemia","volume":"85","author":"Niini","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/sj.leu.2402399","article-title":"AML1 gene over-expression in childhood acute lymphoblastic leukemia","volume":"16","author":"Mikhail","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib23","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/sj.leu.2402479","article-title":"Amplification of AML1 gene is present in childhood acute lymphoblastic leukemia but not in adult, and is not associated with AML1 gene mutation","volume":"16","author":"Penther","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib24","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/sj.leu.2403000","article-title":"Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: an emerging molecular cytogenetic subgroup","volume":"17","author":"Soulier","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.leu.2402849","article-title":"Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases","volume":"17","author":"Harewood","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib26","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/sj.leu.2403140","article-title":"Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome","volume":"17","author":"Robinson","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2007.02.007_bib27","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1073\/pnas.0602360103","article-title":"Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21","volume":"103","author":"Strefford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460807001203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460807001203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:20:55Z","timestamp":1737073255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460807001203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0165460807001203"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2007.02.007","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}